Center for Virtual Care Value and Equity (ViVE)

摘要 重要性：尽管在新冠肺炎大流行期间出现了虚拟护理(VC)计划，但 这些方案的可持续性是未知的，因为人们对卫生服务获得差距、未来 薪酬平等、有效集成到临床工作流程，以及风险投资的许多目标不一致 与按服务付费的支付环境集成。无法获得真实世界的风险投资数据和知识 不同风险投资利益相关者群体的独特需求加剧了健康差距，并可能阻碍 实现财务可持续性。同样，对于循证研究的衡量标准也没有达成共识 具体到风险投资，这阻碍了风险投资的有效性和可持续性 目标：为未来风险投资研究能力的采用和传播奠定坚实的基础。 具体目标：(1)建立和促进内外资源、思想领袖的富有成效的联盟 和利益相关者代表，支持使用真实世界的风险投资数据，并产生创新和 以务实的方式在当地和全国范围内促进风险投资的可扩展股权和价值。 (2)通过以下方式评估关键利益相关者实现公平和可持续风险投资的促进者和障碍 进行两轮半结构化访谈。 (3)开发和验证围绕风险投资股权和价值框架的共识(例如，结果指标)，这将 加快未来的转化性研究，为风险投资服务和政策提供循证指导。 (4)培训劳动力，以实施有效的风险投资股权和价值框架，以改善人类健康。 中心活动：VIVE将通过学习进行研究和支持 对他人的研究。在一定程度上，VIVE将创建新的基础设施，并提供访问真实世界风险投资的途径 支持和推进风险投资研究的研究数据和风险投资专业知识。VIVE将评估协助者 以及关键利益相关者使用半结构化技术实现公平和可持续风险投资的障碍 采访。此外，VIVE将通过围绕风险投资达成共识来改变当前风险投资研究的现状 股权和价值框架。为确保这些框架的有效实施，VIVE将进行 员工培训课程，以提高实施风险投资框架所需的知识和技能。 预期成果：在成功完成我们的研究后，我们预计贡献将包括(1) 通过加快VC的发展来加速NC TraCS(UNC CTSA)临床和翻译科学的发展 研究中心，(2)开发风险投资联盟，通过使研究人员能够推动翻译风险投资研究 访问真实世界的风险投资数据、资源和专业知识，(3)构建和验证风险投资测量 权益和价值的方法和结果指标，以及(4)展示经验证的实际效用 通过在临床研究研究中实施的结果和测量。 第1页，共1页

Abstract Importance: Despite the emergence of virtual care (VC) programs during the COVID-19 pandemic, the sustainability of these programs is unknown because of concerns relating to health access disparities, future payment parity, effective integration into clinical workflows, and the misalignment of many of the goals of VC integration with a fee-for-service payment environment. Lack of access to Real-World VC Data and knowledge of the unique needs of different VC stakeholder groups exacerbates health disparities and can impede attaining financial sustainability. Similarly, there is no consensus on evidence-based research measurements specific to VC, which hinders the effectiveness and sustainability of VC Objective: Lay strong foundation for future adoption and dissemination of VC research capabilities. Specific aims: (1) Build and promote a productive coalition of internal and external resources, thought leaders and stakeholder representatives to enable the use of Real-World VC Data and to generate innovative and pragmatic approaches to advance scalable equity and value in VC both locally and nationally. (2) Assess the facilitators and barriers for key stakeholders to achieve equitable and sustainable VC by conducting two rounds of semi-structured interviews. (3) Develop and validate consensus around VC Equity and Value frameworks (e.g., outcome metrics) that will accelerate future translational research and provide evidence-based guidance for VC service and policy. (4) Train workforce to implement validated VC Equity and Value frameworks to improve human health. Center Activities: ViVE will continuously grow by learning from conducting its research and supporting the research of others. To the extent, ViVE will create new infrastructure and provide access to Real-World VC Research Data and VC Expertise that will support and advance VC research. ViVE will assess the facilitators and barriers to achieving equitable and sustainable VC from key stakeholders using semi-structured interviews. Additionally, ViVE will shift the current status quo of VC research by building consensus around VC equity and value frameworks. To ensure the effective implementation of these frameworks, ViVE will conduct workforce training sessions to improve the knowledge and skills required to implement VC frameworks. Expected outcomes: On successful completion of our research, we expect contributions to include (1) accelerating NC TraCS (UNC CTSA) clinical and translational science by expediting the development of a VC research hub, (2) developing a VC coalition that advances translational VC research by enabling researchers to access Real-World VC Data, resources, and expertise, (3) building and validating VC measurement approaches and outcomes metrics for equity and value, and (4) demonstrating real-world utility of validated outcomes and measurements through implementation in clinical research studies. Page 1 of 1